Toronto Dominion Bank Biomarin Pharmaceutical Inc Transaction History

Toronto Dominion Bank

  • $55.7 Billion
  • Q3 2024

A detailed history of Toronto Dominion Bank transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Toronto Dominion Bank holds 23,942 shares of BMRN stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,942
Previous 23,942 -0.0%
Holding current value
$1.55 Million
Previous $1.68 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $394,173 - $535,920
5,711 Added 31.33%
23,942 $1.68 Million
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $113,356 - $140,451
-1,523 Reduced 7.71%
18,231 $1.5 Million
Q1 2024

May 14, 2024
SELL
$83.81 - $99.0 $34.9 Million - $41.2 Million
-416,497 Reduced 95.47%
19,754 $1.73 Million
Q4 2023

Feb 13, 2024
SELL
$76.22 - $98.51 $35.9 Million - $46.4 Million
-471,503 Reduced 51.94%
436,251 $42.1 Million
Q3 2023

Feb 14, 2024
BUY
$85.07 - $94.48 $73.2 Million - $81.3 Million
860,782 Added 1832.54%
907,754 $80.3 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $73.2 Million - $81.3 Million
860,782 Added 1832.54%
907,754 $80.3 Million
Q2 2023

Feb 14, 2024
SELL
$86.68 - $100.3 $33.7 Million - $39 Million
-389,279 Reduced 89.23%
46,972 $4.07 Million
Q2 2023

Aug 10, 2023
SELL
$86.68 - $100.3 $633,977 - $733,594
-7,314 Reduced 13.47%
46,972 $4.07 Million
Q1 2023

May 11, 2023
SELL
$87.74 - $117.27 $237,336 - $317,215
-2,705 Reduced 4.75%
54,286 $5.28 Million
Q4 2022

Feb 07, 2023
BUY
$80.93 - $108.63 $1.28 Million - $1.72 Million
15,868 Added 38.59%
56,991 $5.9 Million
Q3 2022

Nov 09, 2022
BUY
$82.16 - $96.94 $4,683 - $5,525
57 Added 0.14%
41,123 $3.48 Million
Q2 2022

Aug 11, 2022
BUY
$71.48 - $86.85 $125,018 - $151,900
1,749 Added 4.45%
41,066 $3.4 Million
Q1 2022

May 09, 2022
BUY
$74.28 - $92.69 $234,650 - $292,807
3,159 Added 8.74%
39,317 $3.03 Million
Q4 2021

Feb 04, 2022
BUY
$71.72 - $91.47 $741,871 - $946,165
10,344 Added 40.07%
36,158 $3.2 Million
Q3 2021

Nov 08, 2021
BUY
$74.77 - $85.47 $95,256 - $108,888
1,274 Added 5.19%
25,814 $2 Million
Q2 2021

Aug 13, 2021
BUY
$75.51 - $84.79 $1.85 Million - $2.08 Million
24,540 New
24,540 $2.05 Million

Others Institutions Holding BMRN

# of Institutions
638
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email